Doctors’ Attitudes Towards E-Cigarettes: A Study in the US

Apr.16.2022
Electronic cigarettes may help smokers quit, but only 22% of US doctors recommend them, according to a study.

In the United States, approximately 480,000 people die from smoking each year. Despite the fact that the US Food and Drug Administration (FDA) has not yet approved electronic cigarettes as a smoking cessation device, many people ask their doctors whether using e-cigarettes can be a substitute for tobacco cigarettes or a way to help them quit smoking. E-cigarettes work by heating a liquid that contains nicotine.

 

According to Michael Steinberg, the Director of the Tobacco Dependence Program at Rutgers University's Tobacco Research Center and Chairman of the Department of Medicine at Rutgers Robert Wood Johnson Medical School, who is also the author of a research report, "As more and more evidence shows that electronic cigarettes may be effective for smoking cessation, they may play a key role in reducing cigarette usage and subsequent tobacco-related diseases. Understanding doctors' views on e-cigarettes as a harm-reduction tool is important.

 

This study, published in the online version of the Journal of the American Medical Association, surveyed 2,058 American doctors in 2018 and again in 2019 on their communication with patients about electronic cigarettes. Researchers asked how they would advise two different patients who want to quit smoking: a young woman with a mild addiction who has not yet attempted to quit, and an older man with a severe addiction who has tried multiple methods to quit in the past.

 

Only 22% of the surveyed doctors reported recommending e-cigarettes to their patients, with 10% stating they had done so within the 30 days prior to completing the questionnaire.

 

A recent study has found that doctors are three times more likely to recommend e-cigarettes to heavy smokers who have previously failed to quit smoking. Typically, doctors recommend FDA-approved medication such as nicotine gum or lozenges for mild smokers. Nearly 70% of doctors reported that their patients have asked them questions about e-cigarettes, with one-third saying they were asked within the past 30 days. More than 60% of doctors mistakenly believe that all tobacco products are equally harmful.

 

Cristine Delnevo, director of the Tobacco Research Center at Rutgers University and a professor of Health Behavior, Society and Policy at Rutgers School of Public Health, said, "These findings suggest that it is crucial to address doctors' misconceptions and educate them on the effectiveness of e-cigarettes, particularly in correcting the erroneous belief that all tobacco products are equally harmful, when in fact, combusted tobacco is by far the most dangerous.

 

The study also found that pulmonologists, cardiologists, and physicians who follow the clinical practice guidelines of the US Public Health Service for treating tobacco use and addiction are more likely to recommend e-cigarettes to patients, as well as those who hold harm reduction views and have a history of smoking themselves. However, if patients inquire about e-cigarettes first, physicians are also more likely to recommend them.

 

Source: Cnbeta

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Company | CCELL Launches New GemBar Device with Transparent Tank and Postless Design
Company | CCELL Launches New GemBar Device with Transparent Tank and Postless Design
CCELL has unveiled GemBar via its LinkedIn channel—a new vaporization device featuring a transparent tank for instant capacity checks and a postless design aimed at boosting efficiency and preserving flavor. The company underscores a reliability-first experience, pledging: “We respect every puff. No clogs. No leaks. No burnt taste.”
Sep.15 by 2FIRSTS.ai
Tobacco harm reduction advocates criticize COP11 for limiting public participation and call for inclusion of harm reduction products in discussions
Tobacco harm reduction advocates criticize COP11 for limiting public participation and call for inclusion of harm reduction products in discussions
The Conference of the Parties to the World Health Organization's Framework Convention on Tobacco Control (COP11) will convene in Geneva in November to discuss global tobacco control policies. Tobacco harm reduction advocates worry that the meeting may only avoid further policy damage without achieving substantive progress. They point out that COP11 limits public participation and call for strengthened discussion on safe nicotine products.
Sep.30 by 2FIRSTS.ai
Largest E-Cigarette Seizure in U.S. History: Over 600,000 Products Confiscated from Midwest Goods Warehouse; Company Denies Violations, Calls FDA “Unfair”
Largest E-Cigarette Seizure in U.S. History: Over 600,000 Products Confiscated from Midwest Goods Warehouse; Company Denies Violations, Calls FDA “Unfair”
The U.S. Department of Justice, together with the FDA and the U.S. Marshals Service, raided the warehouse of e-cigarette distributor Midwest Goods in Bensenville, Illinois, seizing more than 600,000 unauthorized e-cigarette products. Midwest Goods denied any violations, stating that the products had been submitted for premarket applications but remained unreviewed by the FDA for an extended period, and criticized the regulations as unfair to small and medium-sized businesses.
Sep.11 by 2FIRSTS.ai
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab will unveil its JuiSour Series at InterTabac in Dortmund, positioned around “aroma burst, sour-sweet balance,enhanced juiciness.” The new line comprises three sub-series — Berry, Candy, and Citrus — breaking through the limitations of traditional acetic acid and introducing the concept of a “Golden Sour-Sweet Ratio” to elevate the sour-aromatic profile and mouthfeel of e-liquids.
Sep.12
Five arrested in Tarlac, Philippines after seizure of illegal e-cigarette products
Five arrested in Tarlac, Philippines after seizure of illegal e-cigarette products
The Philippines conducted a large-scale seizure of unregistered e-cigarettes, and five people were arrested and charged with illegally selling substandard products.
Sep.17 by 2FIRSTS.ai
South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances tobacco law revision, including synthetic nicotine products, anticipating $630 million tax revenue increase.
Oct.16 by 2FIRSTS.ai